Aspecific Uptake of 68GA-PSMA in Paget Disease of the Bone

    loading  Checking for direct PDF access through Ovid

Abstract

68Ga-PSMA plays an increasing role in prostate cancer management, but several instances of false positivity have now been recognized. We present a patient with metastatic prostatic carcinoma who also showed overexpression of PSMA in Paget disease of the humerus on 68Ga-PSMA PET. This probably relates to bone remodeling and increased vascularity. It is important to be aware of this aspecific uptake because its recognition may avoid overstaging and may alter the therapeutic choice.

Related Topics

    loading  Loading Related Articles